Efficacy and Safety of APP13007 for Treatment of Inflammation and Pain After Cataract Surgery Including a Corneal Endothelial Cell Sub-study
Clinical trial NCT04810962 · COMPLETED
Trial details
- NCT number
- NCT04810962
- Sponsor
- Formosa Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-16
- Primary completion
- 2022-07-06
- Enrollment
- 370
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.